Company Quick10K Filing
Deswell Industries
20-F 2020-03-31 Filed 2020-07-17
20-F 2019-03-31 Filed 2019-07-12
20-F 2018-03-31 Filed 2018-07-13
20-F 2017-07-14 Filed 2017-07-14
20-F 2016-07-15 Filed 2016-07-27
20-F 2015-03-31 Filed 2015-07-28
20-F 2014-03-31 Filed 2014-07-11
20-F 2013-03-31 Filed 2013-07-16
20-F 2012-03-31 Filed 2012-07-20
20-F 2011-03-31 Filed 2011-08-02
20-F 2010-03-31 Filed 2010-07-29

Deswell Industries Financials

DSWL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2012-03-312013-03-312014-03-312015-03-312016-07-152017-07-142018-03-312019-03-31
Cash33,07332,03023,27814,32511,9968,07815,19214,371
Accounts Receivable12,4768,2917,9269,5779,20813,15915,91215,734
Inventory15,85211,37611,01210,8288,11410,68812,93313,030
PP&E46,177102,22696,55591,29785,13584,54485,31084,966
Assets121,959112,565100,63696,43987,57190,987100,399100,169
Accounts Payable5,7413,1442,6653,3482,2285,1528,5966,253
Long-Term Debt
Liabilities14,27010,98911,02612,37610,76314,78618,34515,546
Stockholders' Equity107,689101,57689,61084,06376,80876,20181,27983,964
Income Statement ($'000)2012-03-312013-03-312014-03-312015-03-312016-07-152017-07-142018-03-312019-03-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($'000)2012-03-312013-03-312014-03-312015-03-312016-07-152017-07-142018-03-312019-03-31
Cash Operating
Cash Investing
Cash Financing